Nanoview Biosciences is developing proprietary products that support research, translation and delivery of precision medicine. Founded by David Freedman and George Daaboul in 2015, Nanoview Biosciences is backed by investors that include National Science Foundation, Sands Capital Ventures, Northpond Ventures, Esco Ventures, and PBM Capital Group and is headquartered in Boston.
FOUNDED:
2015
INDUSTRY:
Biotechnology, Health Care, Health Diagnostics
FOUNDERS:
David Freedman, George Daaboul
You are seconds away from signing up for the hottest list in New York Tech!
Join the millions and keep up with the stories shaping entrepreneurship. Sign up today.
